FY25 Trading Update

AI SummaryClose X

Verici Dx plc reported strong growth in FY25, with unaudited revenues reaching $3.8 million, up from $3.3 million in 2024, driven by $3.0 million in recognised revenue from Tutivia tests, for which $3.2 million worth were ordered. License income contributed $0.8 million, reflecting expected milestone payments. The company ended the year with $3.3 million in cash, slightly exceeding expectations, and $1.6 million in accounts receivable, supporting a cash runway into the second half of 2026. Key operational achievements included securing Medicare coverage for Tutivia, increasing test adoption to 1,173 ordered tests, and expanding Tutivia usage to 34 centres.

Disclaimer*

Companies

Verici DX (VRCI)
UK 100

Latest directors dealings